MARTINELLI, Silvia
 Distribuzione geografica
Continente #
NA - Nord America 2819
EU - Europa 1311
AS - Asia 115
OC - Oceania 7
SA - Sud America 4
AF - Africa 1
Totale 4257
Nazione #
US - Stati Uniti d'America 2807
GB - Regno Unito 596
IT - Italia 207
SE - Svezia 152
DE - Germania 133
UA - Ucraina 69
CN - Cina 47
TR - Turchia 44
FR - Francia 28
BG - Bulgaria 27
FI - Finlandia 22
IE - Irlanda 22
RU - Federazione Russa 18
BE - Belgio 17
VN - Vietnam 13
CA - Canada 8
AU - Australia 7
RO - Romania 7
BZ - Belize 4
IN - India 4
NL - Olanda 4
MY - Malesia 3
BR - Brasile 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
HR - Croazia 2
AM - Armenia 1
AR - Argentina 1
AT - Austria 1
CL - Cile 1
DZ - Algeria 1
ES - Italia 1
ID - Indonesia 1
IR - Iran 1
MK - Macedonia 1
PK - Pakistan 1
Totale 4257
Città #
Southend 522
Fairfield 475
Woodbridge 288
Houston 238
Chandler 236
Seattle 192
Ashburn 183
Ann Arbor 176
Cambridge 172
Wilmington 146
Nyköping 123
Dearborn 122
Jacksonville 119
Modena 82
Fremont 40
Izmir 29
Princeton 28
Sofia 27
Eugene 26
Bremen 25
San Diego 25
Dublin 22
Brussels 17
Beijing 15
London 13
Dong Ket 12
San Jose 12
Redwood City 9
Des Moines 8
Milan 8
Rome 8
Boardman 7
Hefei 7
Castelnuovo Rangone 6
Falls Church 6
Chicago 5
San Giuliano Milanese 5
Atlanta 4
Belize City 4
Jinan 4
Kunming 4
Perugia 4
Phoenix 4
Saint Petersburg 4
Verona 4
Civitanova Marche 3
Guangzhou 3
Norwalk 3
Perth 3
Shenyang 3
Toronto 3
Albuquerque 2
Amsterdam 2
Ancona 2
Bologna 2
Changsha 2
Clearwater 2
Constanta 2
Fasano 2
Freiburg 2
Fuzhou 2
Genoa 2
Helsinki 2
Indiana 2
Las Vegas 2
Los Angeles 2
Martina Franca 2
Montréal 2
Ottawa 2
Saint Louis 2
Sydney 2
São Paulo 2
Timisoara 2
Zagreb 2
Baotou 1
Berlin 1
Bonn 1
Bristol 1
Brooklyn 1
Calvisano 1
Capistrello 1
Carmignano di Brenta 1
Cassano Magnago 1
Castel Ritaldi 1
Catania 1
Columbus 1
Copenhagen 1
Correggio 1
Dallas 1
Evanston 1
Faenza 1
Genova 1
Groningen 1
Gunzenhausen 1
Hanoi 1
Henderson 1
Horia 1
Huzhou 1
Izano 1
Jiaxing 1
Totale 3556
Nome #
Monocytic population in chronic lymphocytic leukemia shows altered composition and deregulation of genes involved in phagocytosis and inflammation 385
Development of hypogammaglobulinemia in patients treated with imatinib for chronic myeloid leukemia or gastrointestinal stromal tumor 242
Idelalisib impairs T-cell-mediated immunity in chronic lymphocytic leukemia 221
Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia 203
SVILUPPO DI IPOGAMMAGLOBULINEMIA IN PAZIENTI TRATTATI CON IMATINIB PER LEUCEMIA MIELOIDE CRONICA O TUMORI STROMALI GASTROINTESTINALI 184
Increased SHISA3 expression characterizes chronic lymphocytic leukemia patients sensitive to lenalidomide 183
Endothelin-1 promotes survival and chemoresistance in chronic lymphocytic leukemia B cells through eta receptor 182
Lenalidomide interferes with tumor-promoting properties of nurse-like cells in chronic lymphocytic leukemia 181
Targeting neoplastic B cells and harnessing microenvironment: the “double face” of ibrutinib and idelalisib 176
Increased expression of angiopoietin-2 characterizes early B-cell chronic lymphocytic leukemia with poor prognosis 167
The expression of endothelin-1 in chronic lymphocytic leukemia is controlled by epigenetic mechanisms and extracellular stimuli. 164
ANGPT2 promoter methylation is strongly associated with gene expression and prognosis in chronic lymphocytic leukemia 163
Gene expression profiling of acute promyelocytic leukaemia identifies two subtypes mainly associated with Flt3 mutational status 162
Physical contact with endothelial cells through β1- and β2- integrins rescues chronic lymphocytic leukemia from spontaneous and drug-induced apoptosis and induces a peculiar gene expression profile on leukemic cells. 161
Macitentan, a double antagonist of endothelin receptors, efficiently impairs migration and microenvironmental survival signals in chronic lymphocytic leukemia 160
Immunoglobulin mutational status detected through single-round amplification of partial VH region, represents a good prognostic marker for the clinical outcome in chronic lymphocytic leukemia 152
Angiopoietin-2 expression in B-cell chronic lymphocytic leukemia: association with clinical outcome and immunoglobulin heavy-chain mutational status 151
Angiopoietin-2 plasma dosage predicts time to first treatment and overall survival in chronic lymphocytic leukemia. 150
Endothelium-mediated survival of leukemic cells and angiogenesis-related factors are affected by lenalidomide treatment in chronic lymphocytic leukemia 150
Increased angiogenesis induced by chronic lymphocytic leukemia B cells is mediated by leukemia-derived Ang2 and VEGF. 149
Angiopoietin-2 acts as a survival factor for chronic lymphocytic leukemia B cells throughout Tie-2 receptor engagement 143
Lenalidomide in chronic lymphocytic leukemia: The present and future in the era of tyrosine kinase inhibitors 131
Clinical heterogeneity of de novo 11q deletion chronic lymphocytic leukaemia: prognostic relevance of extent of 11q deleted nuclei inside leukemic clone. 111
INTERACTION BETWEEN ENDOTHELIUM AND CHRONIC LYMPHOCYTIC LEUKEMIA B-CELLS RESCUES FROM APOPTOSIS AND MODULATES GENE EXPRESSION PROFILE OF LEUKEMIC CELLS 110
Efficacy of imatinib mesylate as maintenance therapy in adults with acute lymphoblastic leukemia in first complete remission 98
Indoleamine 2, 3-Dioxygenase 1 Mediates Survival Signals in Chronic Lymphocytic Leukemia via Kynurenine/Aryl Hydrocarbon Receptor-Mediated MCL1 Modulation 44
Totale 4323
Categoria #
all - tutte 7525
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7525


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201835 0000 00 00 02177
2018/2019602 29324422 2731 4423 1350135152
2019/20201115 77412564 114171 204142 105547642
2020/2021990 835275119 18076 7984 45875159
2021/2022572 44685125 656 2325 554511955
2022/2023653 72905564 9495 1381 89000
Totale 4323